Fasciola hepatica: the therapeutic potential of a worm secretome.

@article{Robinson2013FasciolaHT,
  title={Fasciola hepatica: the therapeutic potential of a worm secretome.},
  author={Mark W Robinson and John Pius Dalton and Bronwyn A. O'Brien and Sheila Donnelly},
  journal={International journal for parasitology},
  year={2013},
  volume={43 3-4},
  pages={283-91}
}
The success of helminth parasites is partly related to their ability to modulate host immune responses towards an anti-inflammatory/regulatory phenotype. This ability resides with the molecules contained in the secretome of various helminths that have been shown to interact with host immune cells and influence their function. Consequently, there exists a unique opportunity to exploit these molecules for the prophylactic and therapeutic treatment of human pro- and auto-inflammatory disorders… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Antiparasitic DNA vaccines in 21st century.

Acta parasitologica • 2015
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 64 references

A helminth cathelicidin

C. B. Whitchurch, B. A. O'Brien, J. P. Dalton, S. Donnelly
2012

Fasciola hepatica is associated with the failure

M. Baylis, D. J. Williams
2012

Helminth infections and host immune regulation.

Clinical microbiology reviews • 2012
View 1 Excerpt

Th2 Regulation of Viral

D. Georgakopoulos, W. Mitzner, D. Fairweather
2012

Worm therapy: How would you like your medicine?

International journal for parasitology. Drugs and drug resistance • 2012

Similar Papers

Loading similar papers…